ARCHIVES

Ungerleider To Leave NCI For Theradex Corp.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Has To Plan International Meeting On Threat If DNA Biohazards

September 13, 1974

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

June 9, 1995

Lines Drawn Over HHS Appropriations.

October 5, 2007

Comment period for biospecimen network proposal extended.

January 16, 2004

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990

To Cut Colon Cancer Deaths, Reduce Barriers To Screening, NIH Panel Says

February 5, 2010